(UPM, Helsinki, 4 May 2020) - Johana Kuncova-Kallio has been appointed Director, UPM Biomedicals as of 4 of May 2020. She will be responsible for leading and developing UPM Biomedicals business.
Johana is joining UPM from BioNavis Ltd where she has been working as CEO.
Jane Spencer-Fry is leaving UPM at the end of May. We thank Jane for her great contribution in Biomedicals business development and wish Johana warmly welcome to UPM.
We use cookies on this website to ensure the best user experience and target personalised content and relevant advertising. Some cookies are necessary to provide you with a trustworthy service and cannot be declined. Choose the best option for you.
For more information, please see our Privacy Policy.
Your selection
You control your data. We and our business partners use cookies to collect information about you for various purposes:
You may withdraw your consent at any time by clicking the Cookie settings in the footer of each page.
Your selection
You control your data. We and our business partners use cookies to collect information about you for various purposes:
You may withdraw your consent at any time by clicking the Cookie settings in the footer of each page.
UPM Biomedicals
Alvar Aallon katu 1
P.O. Box 380
00101 Helsinki, Finland
Tel. +358 (0)204 15 111
Fax +358 (0)204 15 110